09/25/2026
Congratulations to Dr. John Chabot, Dr. Gulam Manji, and their multidisciplinary colleagues at the Columbia Pancreas Center on the publication of groundbreaking promising new research in pancreatic cancer care. Their innovative combination therapy for metastatic pancreatic cancer marks an important milestone in translational research and reflects Columbia's continued leadership in advancing novel treatments for patients.
As the FDA approved a new targeted therapy for metastatic pancreatic cancer, an early-stage Columbia trial offers another encouraging signal that one of cancerβs most stubborn diseases may be entering a new era of treatment.